Revisión de la descompensación diabética aguda en adultos | 23 JUN 19

Cetoacidosis diabética y síndrome hiperosmolar hiperglucémico

La cetoacidosis diabética (CAD y el síndrome de hiperglucemia hiperosmolar (SHH) son emergencias que amenazan la vida y ocurren en pacientes con diabetes tipo 1 y tipo 2
Autor/a: Esra Karslioglu French, Amy C Donihi, Mary T Korytkowski BMJ 2019;365:l1114
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas
    1 Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009;32:1335-43. 10.2337/dc09-9032 pmid:19564476.
    2 Joint British Diabetes Societies Inpatient Care Group. The management of diabetic ketoacidosis in adults. 2nd edition. 2013. http://www. diabetologists-abcd.org.uk/JBDS/JBDS_IP_DKA_Adults_Revised.pdf. 
    3 Pasquel FJ, Umpierrez GE. Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes Care 2014;37:3124-31. 10.2337/dc14-0984 pmid:25342831. 
    4 Scott AR. Joint British Diabetes Societies (JBDS) for Inpatient Care JBDS hyperosmolar hyperglycaemic guidelines group. Management of hyperosmolar hyperglycaemic state in adults with diabetes. Diabet Med 2015;32:714-24. 10.1111/dme.12757 pmid:25980647. 
    5 Handelsman Y, Henry RR, Bloomgarden ZT, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement On The Association Of SGLT-2 Inhibitors and Diabetic Ketoacidosis. Endocr Pract 2016;22:753-62. 10.4158/EP161292. PS pmid:27082665.
    6 American Diabetes Association. 15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019;42(Suppl 1):S173-81. 10.2337/dc19-S015 pmid:30559241.
    7 Umpierrez G, Korytkowski M. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol 2016;12:222-32. 10.1038/ nrendo.2016.15 pmid:26893262.
    8 Wachtel TJ, Tetu-Mouradjian LM, Goldman DL, Ellis SE, O’Sullivan PS. Hyperosmolarity and acidosis in diabetes mellitus: a three-year experience in Rhode Island. J Gen Intern Med 1991;6:495-502. 10.1007/BF02598216 pmid:1765864.
    9 Munro JF, Campbell IW, McCuish AC, Duncan LJ. Euglycaemic diabetic ketoacidosis. Br Med J 1973;2:578-80. 10.1136/ bmj.2.5866.578 pmid:4197425. 
    10 Dhatariya KK, Umpierrez GE. Guidelines for management of diabetic ketoacidosis: time to revise?Lancet Diabetes Endocrinol 2017;5:321-3. 10.1016/S2213-8587(17)30093-1 pmid:28372975. 
    11 Troy PJ, Clark RP, Kakarala SG, Burns J, Silverman IE, Shore E. Cerebral edema during treatment of diabetic ketoacidosis in an adult with new onset diabetes. Neurocrit Care 2005;2:55-8. 10.1385/ NCC:2:1:055 pmid:16174971. 
    12 Benoit SR, Zhang Y, Geiss LS, Gregg EW, Albright A. Trends in Diabetic Ketoacidosis Hospitalizations and In-Hospital Mortality - United States, 2000-2014. MMWR Morb Mortal Wkly Rep 2018;67:362-5. 10.15585/ mmwr.mm6712a3 pmid:29596400. 
    13 Zhong VW, Juhaeri J, Mayer-Davis EJ. Trends in Hospital Admission for Diabetic Ketoacidosis in Adults With Type 1 and Type 2 Diabetes in England, 1998-2013: A Retrospective Cohort Study. Diabetes Care 2018;41:1870-7. 10.2337/dc17-1583 pmid:29386248. 
    14 Javor KA, Kotsanos JG, McDonald RC, Baron AD, Kesterson JG, Tierney WM. Diabetic ketoacidosis charges relative to medical charges of adult patients with type I diabetes. Diabetes Care 1997;20:349-54. 10.2337/ diacare.20.3.349 pmid:9051386. 
    15 Centers for Disease Control and Prevention. National Diabetes Statistics Report. 2017. https://www.cdc.gov/diabetes/data/statistics/statistics-report.html. 
    16 Vellanki P, Umpierrez GE. Diabetic ketoacidosis: A common debut of diabetes among african americans with type 2 diabetes. Endocr Pract 2017;23:971-8. 10.4158/EP161679.RA pmid:28534682. 
    17 Cefalu WT, Dawes DE, Gavlak G, et al. Insulin Access and Affordability Working Group: Conclusions and Recommendations. Diabetes Care 2018;41:1299-311. 10.2337/dci18-0019 pmid:29739814. 
    18 Dhatariya KK, Skedgel C, Fordham R. The cost of treating diabetic ketoacidosis in the UK: a national survey of hospital resource use. Diabet Med 2017;34:1361-6. 10.1111/dme.13427 pmid:28727175. 
    19 Delaney MF, Zisman A, Kettyle WM. Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Endocrinol Metab Clin North Am 2000;29:683-705, V. 10.1016/S0889-8529(05)70159- 6 pmid:11149157. 
    20 Fadini GP, de Kreutzenberg SV, Rigato M, et al. Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center. Diabetes Res Clin Pract 2011;94:172-9. 10.1016/j.diabres.2011.06.018 pmid:21752485. 
    21 Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition. Diabetes Care 2015;38:1687-93. 10.2337/dc15-0843 pmid:26078479. 
    22 Meyer EJ, Gabb G, Jesudason D. SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A South Australian Clinical Case Series and Australian Spontaneous Adverse Event Notifications. Diabetes Care 2018;41:e47-9. 10.2337/dc17-1721 pmid:29440112. 
    23 Ueda P, Svanström H, Melbye M, et al. Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study. BMJ 2018;363:k4365. 10.1136/bmj.k4365 pmid:30429124. 
    24 Modi A, Agrawal A, Morgan F. Euglycemic Diabetic Ketoacidosis: A Review. Curr Diabetes Rev 2017;13:315-21. 10.2174/1573399812666160421121307 pmid:27097605.
    51 Wachtel TJ, Silliman RA, Lamberton P. Predisposing factors for the diabetic hyperosmolar state. Arch Intern Med 1988;148:747. 10.1001/ archinte.1988.00380030253040 pmid:3341875.
    52 Arieff AI, Carroll HJ. Cerebral edema and depression of sensorium in nonketotic hyperosmolar coma. Diabetes 1974;23:525-31. 10.2337/ diab.23.6.525 pmid:4834291.
    53 Hara JS, Rahbar AJ, Jeffres MN, Izuora KE. Impact of a hyperglycemic crises protocol. Endocr Pract 2013;19:953-62. 10.4158/EP13077. OR pmid:23807521.
    54 Bull SV, Douglas IS, Foster M, Albert RK. Mandatory protocol for treating adult patients with diabetic ketoacidosis decreases intensive care unit and hospital lengths of stay: results of a nonrandomized trial. Crit Care Med 2007;35:41-6. 10.1097/01.CCM.0000249825.18677. D2 pmid:17095944.
    55 Thuzar M, Malabu UH, Tisdell B, Sangla KS. Use of a standardised diabetic ketoacidosis management protocol improved clinical outcomes. Diabetes Res Clin Pract 2014;104:e8-11. 10.1016/j. diabres.2014.01.016 pmid:24507867.
    56 Ullal J, Aloi JA, Reyes-Umpierrez D, et al. Comparison of Computer- Guided Versus Standard Insulin Infusion Regimens in Patients With Diabetic Ketoacidosis. J Diabetes Sci Technol 2018;12:39-46. 10.1177/1932296817750899 pmid:29291648.
    57 Laliberte B, Yeung SYA, Gonzales JP. Impact of diabetic ketoacidosis management in the medical intensive care unit after order set implementation. Int J Pharm Pract 2017;25:238-43. 10.1111/ ijpp.12346 pmid:28338247.
    58 Martin C, McKinney ZJ, Hoody D, Fish L. Diabetic ketoacidosis critical care pathway implementation: Incorporation into emr significantly decreases length of stay. Endocr Pract 2016;22:673-8. 10.4158/EP151073. OR pmid:27176140.
    59 Devalia B. Adherance to protocol during the acute management of diabetic ketoacidosis: would specialist involvement lead to better outcomes?Int J Clin Pract 2010;64:1580-2. 10.1111/j.1742- 1241.2010.02348.x pmid:20846206.
    60 Tran TTT, Pease A, Wood AJ, et al. Review of Evidence for Adult Diabetic Ketoacidosis Management Protocols. Front Endocrinol (Lausanne) 2017;8:106. 10.3389/fendo.2017.00106 pmid:28659865.
    61 Patiño AM, Marsh RH, Nilles EJ, Baugh CW, Rouhani SA, Kayden S. Facing the Shortage of IV Fluids - A Hospital-Based Oral Rehydration Strategy. N Engl J Med 2018;378:1475-7. 10.1056/ NEJMp1801772 pmid:29561701.
    62 Misra S, Oliver NS. Utility of ketone measurement in the prevention, diagnosis and management of diabetic ketoacidosis. Diabet Med 2015;32:14-23. 10.1111/dme.12604 pmid:25307274.
    63 Dhatariya KK, Vellanki P. Treatment of Diabetic Ketoacidosis (DKA)/ Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA). Curr Diab Rep 2017;17:33. 10.1007/s11892-017-0857-4 pmid:28364357.
    64 Ginde AA, Pelletier AJ, Camargo CA Jr. National study of U.S. emergency department visits with diabetic ketoacidosis, 1993-2003. Diabetes Care 2006;29:2117-9. 10.2337/dc06-
 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024